Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE: 600381)
Health Care · Pharmaceuticals · CN
CN¥4.13
-1.67% today · -10.2% 1Y
Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE: 600381) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $352.91M and employs 134 people.
Over the last twelve months the share price has lost 10.2%, trading between 2.48 and 5.90.
Tweenvest scores Qinghai Spring Medicinal Resources Technology Co., Ltd. across four factors: quality 61/100, value 54/100, growth 98/100. Its strongest factor is growth.
600381 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $352.91M
- Revenue (TTM)
- $40.87M
- P/E
- —
- EPS
- -0.15
- Dividend yield
- —
- Beta (5Y)
- 0.70
- 52-week high
- CN¥5.90
- 52-week low
- CN¥2.48
- Avg volume (3M)
- —
- Shares outstanding
- 572.36M
- Employees
- 134
- Next earnings
- —
About Qinghai Spring Medicinal Resources Technology Co., Ltd.
Qinghai Spring Medicinal Resources Technology Co., Ltd. specializes in the research, development, and commercialization of cordyceps products. Its operations further extend to the distribution of beverages and aquatic items, providing advertising solutions, and conducting foreign investment activities. The company was established in 2003 and is headquartered in Xining, China.
- ISIN
- CNE0000017W0
- Founded
- 1998
- Listed since
- May 8, 2001
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ASKA Pharmaceutical Holdings Co.,Ltd.TSE: 4886 | $359.39M | ¥2,004.00 | -1.28% |
| Suzhou Fushilai Pharmaceutical Co., Ltd.SZSE: 301258 | $357.63M | CN¥27.04 | -1.31% |
| Turn Therapeutics Inc.NasdaqGM: TTRX | $357.46M | $11.48 | -4.33% |
| ShanXi C&Y Pharmaceutical Group Co.,LTD.SZSE: 300254 | $356.35M | CN¥9.28 | +0.98% |
| Canopy Growth CorporationTSX: WEED | $349.86M | CA$1.18 | -2.48% |
| Jilin Jian Yisheng Pharmaceutical Co., Ltd.SZSE: 002566 | $349.82M | CN¥7.08 | +0.28% |
| Deva Holding A.S.IBSE: DEVA | $348.01M | TL85.85 | -3.54% |
| Hainan Huluwa Pharmaceutical Group Co., Ltd.SHSE: 605199 | $347.06M | CN¥5.81 | +1.75% |
Figures last refreshed Oct 11, 2026.